Malawi Pharmaceutical Distributors (MPD) has signed a distributorship agreement with global healthcare and pharmaceutical giant Johnson & Johnson, a move expected to improve access to quality medicines and strengthen the country’s pharmaceutical supply chain.
Mwase said the agreement is expected to improve the availability of medicines while also helping Malawi save foreign exchange by cutting the cost of importing pharmaceutical supplies.
“This partnership will ensure that Johnson & Johnson pharmaceutical products are more accessible locally, while contributing to efforts to reduce forex expenditure on medicine imports,” he said.
Pharmaceutical Society of Malawi (PHASOM) President William Mpute has welcomed the partnership, describing it as a significant milestone for the country’s healthcare sector.
Mpute said the collaboration will help bridge medicine supply gaps, improve the availability of essential drugs and support ongoing efforts to strengthen Malawi’s local pharmaceutical supply chain.Kamphangala says MSCA ruling on Mulli Companies a great lesson
He added that the agreement aligns with national efforts to reduce dependence on foreign exchange for drug imports while ensuring that patients have reliable access to high-quality medicines.
The partnership is expected to enhance the efficiency of pharmaceutical distribution in Malawi and contribute to improved healthcare delivery across the country.Cannabis Pharmaceutical Factory To Roll Out
